Comparison of Indicators of Metabolic Syndrome in Iranian Smokers

Background: Worldwide non communicable diseases are increasingly recognized as a major cause of morbidity and mortality. The metabolic syndrome is a common metabolic disorder that results from the increasing prevalence of obesity.The disorder is defined in various ways. This study determines the comparison of indicators of metabolic syndrome in Iranian smokers population.

Patients and Methods: A total of 1,024 Iranian subjects aged 30 to 70 participated in this cross sectional study. Standard questionnaire was completing regarding smoking habits, medications, past medical history, physical activity, blood pressure, fasting blood suger, total cholestrol HDL and triglycerides. The diagnosis of metabolic syndrome was based on the IDF criteria.

Results: As defined by the modified IDF criteria, (45.9%) had the MS at baseline assessment. The risk of incidence of the metabolic syndrome among smokers was significantly (p<0.008) greater than nonsmokers. Among men without the MS at entry, body weight gain, compared with never smokers, was significantly (p<0.007) higher in smokers who had quit smoking. It is important for the prevention of the MS not only to quit smoking but also to prevent weight gain after smoking cessation.

Conclusions: Although many cardiovascular diseases (CVDs) can be treated or prevented many people die from CVDs. Reducing the rate of cigarette smoking, body weight, blood pressure, blood cholesterol, and blood glucose all have a benefit impact on major biological cardiovascular risk factors. Behaviors such as stopping smoking, taking regular physical activity and eating a healthy diet promote health and have no known harmful effects.